Initial report of 3rd line combination chemotherapy comprising gemcitabine, cisplatin and paclitaxel for advanced germ cell carcinoma

Takashi Saika, Kohei Edamura, Makoto Kobuke, Tatsuya Uesugi, Yasuyuki Kobayashi, Akira Takao, Haruki Kaku, Yasutomo Nasu, Hiromi Kumon

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Initial report of 3<sup>rd</sup> line combination chemotherapy comprising gemcitabine, cisplatin and paclitaxel for advanced germ cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences